Glytec launches new insulin management system
WEBMarch 30, 2021 By Sean Whooley. Glytec announced today that it introduced the latest version of its eGlycemic Management System (eGMS) for managing insulin. Waltham, Mass.-based Glytec’s eGMS is centered around the FDA-cleared Glucommander algorithm, which leverages real-time and historical data to recommend insulin dosing by learning each ...
How Embecta is 'uniquely positioned' in diabetes space following ...
WEBApr 5, 2022 · Unlike most “new” companies, Embecta enters the playing field with nearly a century of history in diabetes. Nearly one year after BD (NYSE:BDX) announced its intent to spinoff its diabetes business, Embecta (Nasdaq:EMBC) now stands on its own.. On April 1, the spinoff was made official, and Embecta became a standalone, publicly-traded company aiming to make waves in the diabetes industry.
BD chooses 'embecta' as new name for Diabetes Care spinoff, …
WEBDec 6, 2021 · BD (NYSE:BDX) announced today that it named its Diabetes Care business — which it plans to spin off next year — “embecta.”. Franklin Lakes, New Jersey-based BD confirmed in May that it plans to spin off its Diabetes Care business as an independent, publicly-traded company during the first half of 2022 and confirmed today that it expects that spinoff to close in the second quarter of ...
Medtronic launches 7-day infusion set for insulin pumps in U.S.
WEBNovember 15, 2022 By Sean Whooley. Medtronic (NYSE:MDT) announced today that it launched its Medtronic Extended Infusion set for seven-day wear with insulin delivery. The Medtronic Extended Infusion Set represents the first and only infusion set labeled for wearing of up to seven days. The infusion set for delivering insulin from a pump to the ...
Enable Injections inks deal with Sanofi for drug delivery platform
WEBJun 3, 2019 · Enable Injections said today that it inked a partnership with Sanofi for its enFuse drug delivery platform. Cincinnati-based Enable Injections developed the enFuse device to enable patient-administered subcutaneous delivery of high-volume therapeutics outside of the hospital. The on-body drug delivery platform has a …
FDA approves, expands label for Eli Lilly's rapid-acting insulin for ...
WEBAug 16, 2021 · Eli Lilly (NYSE:LLY) announced today that it received FDA approval and expanded labeling for its Lyumjev rapid-acting insulin.. Indianapolis-based Eli Lilly’s Lyumjev (insulin lispro-aabc injection) 100 units/mL holds indication to improve glycemic control in adults with type 1 and type 2 diabetes, including administration via continuous subcutaneous insulin infusion (CSII) with an insulin pump.
FDA approves Genosyl system from Vero Biotech for OR settings
WEBFeb 3, 2023 · The Genosyl system. [Image from the Vero Biotech website] Vero Biotech announced that the FDA approved its second-generation Genosyl system for use with rebreathing anesthesia in the operating room setting. Atlanta-based Vero Biotech designed Genosyl for inhaled nitric oxide (iNO) delivery. This approval covers the second-generation Genosyl device.
BD applies to start shipping Alaris pumps again
WEBApr 26, 2021 · (Image courtesy of BD) BD said today that it has applied to the FDA for a new clearance for its recall-plagued Alaris infusion pump system.. BD has had shipments of Alaris pumps on hold after the FDA called for a comprehensive 510(k) submission to cover a host of software fixes needed following a Class I-level recall in March 2020. Pumps are only going to health providers with an immediate ...
Integrity Applications changes company name to GlucoTrack
WEBMar 14, 2022 · Integrity Applications (Nasdaq:IGAP) announced today that it completed the change of its corporate name to GlucoTrack. Rutherford, New Jersey-based GlucoTrack confirmed the change of its ticker symbol on the Nasdaq capital market to “GCTK,” which was made effective at the commencement of trading today, …
How CGM tech has advanced in the 21st century
WEBMar 11, 2021 · The rapid evolution of the continuous glucose monitor (CGM) has brought flexibility and convenience to diabetes control. Continuous glucose monitors (CGMs) have transformed how many people with diabetes manage blood sugar, but attempts to monitor blood glucose have a long history. Efforts to manage glucose kicked off in earnest when researchers began measuring glucose in urine in the mid-1800s.
Skip to content